Authors:
Koritzinsky, M
Wouters, BG
Amellem, O
Pettersen, EO
Citation: M. Koritzinsky et al., Cell cycle progression and radiation survival following prolonged hypoxia and re-oxygenation, INT J RAD B, 77(3), 2001, pp. 319-328
Authors:
Seagroves, TN
Ryan, HE
Lu, H
Wouters, BG
Knapp, M
Thibault, P
Laderoute, K
Johnson, RS
Citation: Tn. Seagroves et al., Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells, MOL CELL B, 21(10), 2001, pp. 3436-3444
Authors:
Tsirigotis, M
Zhang, M
Chiu, RK
Wouters, BG
Gray, DA
Citation: M. Tsirigotis et al., Sensitivity of mammalian cells expressing mutant ubiquitin to protein-damaging agents, J BIOL CHEM, 276(49), 2001, pp. 46073-46078
Authors:
Wouters, BG
Delahoussaye, YM
Evans, JW
Birrell, GW
Dorie, MJ
Wang, JL
MacDermed, D
Chiu, RK
Brown, JM
Citation: Bg. Wouters et al., Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine, CANCER RES, 61(1), 2001, pp. 145-152
Authors:
Wouters, BG
Denko, NC
Giaccia, AJ
Brown, JM
Citation: Bg. Wouters et al., A p53 and apoptotic independent role for p21(waf1) in tumour response to radiation therapy, ONCOGENE, 18(47), 1999, pp. 6540-6545
Citation: Bg. Wouters et al., Tirapazamine: A new drug producing tumor specific enhancement of platinum-based chemotherapy in non-small-cell lung cancer, ANN ONCOL, 10, 1999, pp. 29-33
Authors:
Kovacs, MS
Hocking, DJ
Evans, JW
Slim, BG
Wouters, BG
Brown, JM
Citation: Ms. Kovacs et al., Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin, BR J CANC, 80(8), 1999, pp. 1245-1251